Implementing TMB measurement in clinical practice: considerations on assay requirements

Clinical evidence demonstrates that treatment with immune checkpoint inhibitor immunotherapy agents can have considerable benefit across multiple tumours. However, there is a need for the development of predictive biomarkers that identify patients who are most likely to respond to immunotherapy. Com...

Descripción completa

Detalles Bibliográficos
Autores principales: Büttner, Reinhard, Longshore, John W, López-Ríos, Fernando, Merkelbach-Bruse, Sabine, Normanno, Nicola, Rouleau, Etienne, Penault-Llorca, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350758/
https://www.ncbi.nlm.nih.gov/pubmed/30792906
http://dx.doi.org/10.1136/esmoopen-2018-000442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350758/
https://www.ncbi.nlm.nih.gov/pubmed/30792906
http://dx.doi.org/10.1136/esmoopen-2018-000442

Ejemplares similares